Rhythm Biosciences Ltd. (AU:RHY)
ASX:RHY
Australian Market
Holding AU:RHY?
Track your performance easily

Rhythm Biosciences Ltd. (RHY) Financial Statements

5 Followers

Rhythm Biosciences Ltd. Financial Overview

Rhythm Biosciences Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.029; its P/E ratio is -3.38; Rhythm Biosciences Ltd. is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19
Income Statement-
Total Revenue----
Gross Profit----
EBIT----
EBITDA----
Net Income Common Stockholders----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 7.60MAU$ 2.27MAU$ 1.84MAU$ 4.77M
Total AssetsAU$ 8.44MAU$ 3.07MAU$ 2.65MAU$ 6.23M
Total DebtAU$ 170.14KAU$ 0.00AU$ 42.44KAU$ 0.00
Net DebtAU$ -7.43MAU$ -2.27MAU$ -1.80MAU$ -4.77M
Total LiabilitiesAU$ 1.07MAU$ 1.36MAU$ 802.85KAU$ 379.71K
Stockholders EquityAU$ 7.37MAU$ 1.71MAU$ 1.84MAU$ 5.85M
Cash Flow-
Free Cash Flow----
Operating Cash Flow----
Investing Cash Flow----
Financing Cash Flow----
Currency in AUD

Rhythm Biosciences Ltd. Earnings and Revenue History

Rhythm Biosciences Ltd. Debt to Assets

Rhythm Biosciences Ltd. Cash Flow

Rhythm Biosciences Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis